Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
EHAB Stock Forecast 2025-2026
$7.32
Current Price
$387.38M
Market Cap
Buy 1
Hold 4
Sell 0
Wall St Analyst Ratings
Distance to EHAB Price Targets
+63.9%
To High Target of $12.00
+36.6%
To Median Target of $10.00
+23.0%
To Low Target of $9.00
EHAB Price Momentum
-7.1%
1 Week Change
-32.2%
1 Month Change
-17.1%
1 Year Change
-6.3%
Year-to-Date Change
-32.9%
From 52W High of $10.91
+6.9%
From 52W Low of $6.85
📊 TOP ANALYST CALLS
Did EHAB Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Enhabit is one of their latest high-conviction picks.
Latest EHAB Stock Price Targets & Analyst Predictions
Based on our analysis of 13 Wall Street analysts, EHAB has a neutral consensus with a median price target of $10.00 (ranging from $9.00 to $12.00). Currently trading at $7.32, the median forecast implies a 36.6% upside. This outlook is supported by 1 Buy, 4 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Ryan Langston at TD Cowen, projecting a 63.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
EHAB Analyst Ratings
1
Buy
4
Hold
0
Sell
EHAB Price Target Range
Low
$9.00
Average
$10.00
High
$12.00
Current: $7.32
Latest EHAB Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for EHAB.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 9, 2024 | Jefferies | Brian Tanquilut | Buy | Upgrade | $9.50 |
| Nov 19, 2024 | Leerink Partners | Market Perform | Reiterates | $0.00 | |
| Jun 27, 2024 | B of A Securities | Joanna Gajuk | Underperform | Maintains | $8.00 |
| May 14, 2024 | Leerink Partners | Whit Mayo | Market Perform | Upgrade | $8.50 |
| May 9, 2024 | Jefferies | Brian Tanquilut | Hold | Downgrade | $8.75 |
| Mar 11, 2024 | TD Cowen | Ryan Langston | Market Perform | Maintains | $11.00 |
| Mar 7, 2024 | Oppenheimer | Michael Wiederhorn | Perform | Maintains | $0.00 |
| Mar 7, 2024 | UBS | A.J. Rice | Neutral | Upgrade | $9.50 |
| Mar 6, 2024 | Jefferies | Brian Tanquilut | Buy | Maintains | $14.00 |
| Dec 12, 2023 | TD Cowen | Ryan Langston | Market Perform | Initiates | $12.00 |
| Aug 11, 2023 | Credit Suisse | Jonathan Yong | Neutral | Maintains | $12.00 |
| Jul 17, 2023 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $13.00 |
| Mar 16, 2023 | Goldman Sachs | Jamie Perse | Neutral | Initiates | $15.00 |
| Feb 17, 2023 | Citigroup | Jason Cassorla | Neutral | Maintains | $18.00 |
| Feb 16, 2023 | Credit Suisse | Jonathan Yong | Neutral | Reiterates | $15.00 |
| Dec 13, 2022 | CJS Securities | Larry Solow | Market Perform | Initiates | $18.00 |
| Dec 8, 2022 | UBS | Andrew Mok | Sell | Initiates | $12.00 |
| Dec 6, 2022 | Stifel | Tao Qiu | Buy | Initiates | $17.00 |
| Nov 4, 2022 | Credit Suisse | Jonathan Yong | Neutral | Maintains | $15.00 |
| Oct 14, 2022 | Oppenheimer | Michael Wiederhorn | Perform | Initiates | $0.00 |
Enhabit Inc. (EHAB) Competitors
The following stocks are similar to Enhabit based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Enhabit Inc. (EHAB) Financial Data
Enhabit Inc. has a market capitalization of $387.38M with a P/E ratio of 0.0x. The company generates $1.03B in trailing twelve-month revenue with a -13.4% profit margin.
Revenue growth is -1.0% quarter-over-quarter, while maintaining an operating margin of +6.1% and return on equity of -21.4%.
Valuation Metrics
Market Cap
$387.38M
Enterprise Value
$1.02B
P/E Ratio
0.0x
PEG Ratio
27.3x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
-1.0%
Gross Margin
+49.9%
Operating Margin
+6.1%
Net Margin
-13.4%
EPS Growth
+8,800.0%
Financial Health
Cash/Price Ratio
+10.7%
Current Ratio
1.5x
Debt/Equity
94.9x
ROE
-21.4%
ROA
+2.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Enhabit Inc. (EHAB) Business Model
About Enhabit Inc.
What They Do
Provides home health and hospice care services.
Business Model
Enhabit Inc. generates revenue by offering home health and hospice care services across the U.S., focusing on high-quality, patient-centered care. Their business model is centered on supporting patients transitioning from hospital to home, thus facilitating post-acute care and addressing the needs of patients with serious illnesses through palliative care.
Additional Information
The company operates with a commitment to innovation and high care standards, which not only improve patient outcomes but also reduce hospital readmissions. As the demand for personalized in-home care grows with an aging population, Enhabit Inc. plays a crucial role in the healthcare ecosystem by providing scalable and effective solutions.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
10,700
CEO
Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T.
Country
United States
IPO Year
2022
Website
www.ehab.comEnhabit Inc. (EHAB) Latest News & Analysis
Latest News
Enhabit Announces Participation in Goldman Sachs 46th Annual Global Healthcare Conference
1 month ago
Quick Summary
Enhabit, Inc. (NYSE: EHAB) will participate in the Goldman Sachs 46th Annual Global Healthcare Conference on June 10 at 10 a.m. EDT, featuring a live webcast with CEO Barb Jacobsmeyer and CFO Ryan Solomon.
Why It Matters
Enhabit's participation in a major healthcare conference signals its visibility and engagement with investors, potentially impacting stock performance and market perception.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Enhabit, Inc. (NYSE: EHAB) will hold its Q1 2025 earnings conference call on May 8, 2025, at 10:00 AM ET, featuring key company executives and analysts from major firms.
Why It Matters
The upcoming earnings call for Enhabit, Inc. offers insights into financial performance and guidance, influencing stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Enhabit Reports First Quarter 2025 Financial Results
2 months ago
Quick Summary
Enhabit, Inc. (NYSE: EHAB) reported Q1 2025 results with a 3.7% sequential increase in home health census and a 12.3% year-over-year rise in hospice census, indicating strong growth and improved profitability.
Why It Matters
Enhabit's growth in home health and hospice census suggests robust demand, potentially driving revenue and profitability, which can positively impact stock performance and investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Enhabit (EHAB) Q1 Earnings Top Estimates
2 months ago
Quick Summary
Enhabit (EHAB) reported quarterly earnings of $0.10 per share, surpassing the Zacks Consensus Estimate of $0.07 and up from $0.07 per share year-over-year.
Why It Matters
Enhabit's earnings beat expectations and show year-over-year growth, indicating stronger financial performance and potentially boosting investor confidence and stock value.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Enhabit, Inc. (NYSE: EHAB) will report Q1 results on May 7, 2025, and host a conference call on May 8, 2025, at 10 a.m. EDT. Participation details include a toll-free number and conference ID.
Why It Matters
Enhabit's upcoming earnings report and conference call will provide insights into its financial health and performance, influencing investor sentiment and stock price movements.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Enhabit (EHAB) and Doximity (DOCS) have been compared to their sector's performance year-to-date. Specific performance metrics were not provided in the excerpt.
Why It Matters
Performance comparison reveals relative strength or weakness, influencing investor sentiment and potential stock price movements for Enhabit and Doximity within their sectors.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About EHAB Stock
What is Enhabit Inc.'s (EHAB) stock forecast for 2026?
Based on our analysis of 13 Wall Street analysts, Enhabit Inc. (EHAB) has a median price target of $10.00. The highest price target is $12.00 and the lowest is $9.00.
Is EHAB stock a good investment in 2026?
According to current analyst ratings, EHAB has 1 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.32. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for EHAB stock?
Wall Street analysts predict EHAB stock could reach $10.00 in the next 12 months. This represents a 36.6% increase from the current price of $7.32. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Enhabit Inc.'s business model?
Enhabit Inc. generates revenue by offering home health and hospice care services across the U.S., focusing on high-quality, patient-centered care. Their business model is centered on supporting patients transitioning from hospital to home, thus facilitating post-acute care and addressing the needs of patients with serious illnesses through palliative care.
What is the highest forecasted price for EHAB Enhabit Inc.?
The highest price target for EHAB is $12.00 from Ryan Langston at TD Cowen, which represents a 63.9% increase from the current price of $7.32.
What is the lowest forecasted price for EHAB Enhabit Inc.?
The lowest price target for EHAB is $9.00 from at , which represents a 23.0% increase from the current price of $7.32.
What is the overall EHAB consensus from analysts for Enhabit Inc.?
The overall analyst consensus for EHAB is neutral. Out of 13 Wall Street analysts, 1 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $10.00.
How accurate are EHAB stock price projections?
Stock price projections, including those for Enhabit Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 8, 2025 2:49 AM UTC